Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2007
08/30/2007WO2007098127A2 Compositions for treating wounds and processes for their preparation
08/30/2007WO2007098114A2 Clotting and healing compositions containing keratin biomaterials
08/30/2007WO2007098106A2 Respiratory tract delivery of interferon-tau
08/30/2007WO2007097989A2 A composition and method for the efficacious and safe administration of halopyruvate for the treatment of cancer
08/30/2007WO2007097980A2 Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy
08/30/2007WO2007097961A1 Use of azurocidin inhibitors in prevention and treatment of ocular vascular leakage
08/30/2007WO2007097940A2 Reca inhibitors with antibiotic activity, compositions and methods of use
08/30/2007WO2007097922A2 Receptor-based blood detoxification system
08/30/2007WO2007097903A2 Hiv fusion inhibitor peptides with improved biological properties
08/30/2007WO2007097742A1 Methods relating to glucocorticoid induced receptors
08/30/2007WO2007097624A1 Pharmaceutical compositions for the treatment of influenza infections
08/30/2007WO2007097493A1 DE-DIFFERENTIATION OF ASTROCYTES INTO NEURAL STEM CELL USING Shh
08/30/2007WO2007097469A1 A dominant negative peptide of imp-3, polynucleotide encoding the same, pharmaceutical composition containing the same, and methods for treating or preventing cancer
08/30/2007WO2007097358A1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
08/30/2007WO2007097315A1 Enteric gelatinous nutrient and method of preparing the same
08/30/2007WO2007097251A1 PEPTIDE VACCINE FOR INDUCING PRODUCTION OF ANTI-AMYLOID-β-PEPTIDE ANTIBODY
08/30/2007WO2007096859A2 Protection of the retina against laser injury by adnf peptides such as nap and sal
08/30/2007WO2007096855A2 Angiotensin-i-converting enzyme inhibitory
08/30/2007WO2007096854A1 Compositions and methods for modulating an immune response
08/30/2007WO2007096745A1 Methods for the treatment of macular degeneration and related eye conditions
08/30/2007WO2007096596A2 Use of il-8 for the treatment of crohn' s disease
08/30/2007WO2007096431A1 Insulin derivatives
08/30/2007WO2007096406A1 A method of removing a non-metallic protein inhibitor from a liquid pharmaceutical preparation
08/30/2007WO2007096398A1 Soluble receptors and methods for treating autoimmune or demyelinating diseases
08/30/2007WO2007096332A1 Single-chain insulin analogues and pharmaceutical formulations thereof
08/30/2007WO2007096199A2 Differential diagnostics and therapy of virally induced heart muscle disease
08/30/2007WO2007096142A2 Vascular tumor markers
08/30/2007WO2007096116A1 Coagulation factor x polypeptides with modified activation properties
08/30/2007WO2007096055A1 Combination of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes
08/30/2007WO2007095867A1 Immunomodulatory and anti-tumour peptides
08/30/2007WO2007095830A1 Powder perfusion agent used in the treatment of bovine mastitis and its preparing process
08/30/2007WO2007095748A1 Cancerous disease modifying antibody 141205-05
08/30/2007WO2007095745A1 Cancerous disease modifying antibody 141205-02
08/30/2007WO2007095737A1 Combination therapy for the treatment of diabetes comprising an exendin agonist and a gastrin compound
08/30/2007WO2007095661A1 Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
08/30/2007WO2007095660A1 Peptides and peptide derivatives as well as pharmaceutical compositions containing the same
08/30/2007WO2007095659A1 Peptides and peptide derivatives, preparation thereof and the use thereof for preparing a therapeutic and/or preventative medicament
08/30/2007WO2007079605A3 Template-fixed peptidomimetics with antimicrobial activity
08/30/2007WO2007068252A3 Bovine osteopontin formulations for the improvement of the wound healing process
08/30/2007WO2007065588A8 Pharmaceutical compositions comprising cyclosporin
08/30/2007WO2007063363A3 Method for determining the concentration of the adipocytic form of the fatty acid binding protein (a-fabp, fabp4, p2)
08/30/2007WO2007061829A3 Pharmaceutical composition
08/30/2007WO2007061434A3 A pharmaceutical formulation of glp-1 and its use for treating a metabolic syndrome
08/30/2007WO2007058776A3 Hepatocyte growth factor intron fusion proteins
08/30/2007WO2007050978A3 Methods for the elimination of pathogens and other particulate agents
08/30/2007WO2007040591A3 A ubiquinone composition and a container for its convenient transport and storage
08/30/2007WO2007036792A3 Kit for parenteral administration of medicaments
08/30/2007WO2007027578A3 Methods and compositions for decreasing cohesivity of pathological respiratory tract secretions
08/30/2007WO2007018759A3 Ligand-binding reagents for quenching and improved purification of lipidated proteins
08/30/2007WO2007010394A3 Inhibition of the tumorigenic potential of tumor stem cells by lif and bmps
08/30/2007WO2006136982A3 An isolated recombinant vaccinia virus complement control protein (hrvcp) polypeptide
08/30/2007WO2006134497A3 Uses of recombinant super-compound interferons
08/30/2007WO2006122162A3 Use of peptides derived from the growth factor amp-18 for the treatment of mucositis
08/30/2007WO2006063837A8 Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
08/30/2007WO2005121328A8 Method for ameliorating an inflammatory skin condition
08/30/2007WO2005062954A3 Modulation of hcn channels by second messengers
08/30/2007WO2004009836A3 Pr/set-domain containing nucleic acids, polypeptides, antibodies and methods of use
08/30/2007WO2003095622A3 Proteins associated with cell growth, differentiation, and death
08/30/2007US20070203749 Business methods for compounds for treatment of proliferative disorders
08/30/2007US20070203329 Soluble kinase receptor for use in identifying modulators to treat and prevent cell proliferative, respiratory, kidney and liver disorders
08/30/2007US20070203327 Transcription factor of MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substanaces
08/30/2007US20070203326 Integrin-linked kinase and its uses
08/30/2007US20070203325 Integrase-dirived HIV-inhibiting agents
08/30/2007US20070203157 inhibitors of potassium channel function; to treat arrhythmia; 7-(3,4-Dichlorophenyl)-6-(4-fluorophenylsulfonyl)-2,5-dimethyl-4,7-dihydropyrazolo[1,5-a]pyrimidine
08/30/2007US20070203138 Novel Compounds and Compositions as Cathepsin S Inhibitors
08/30/2007US20070203108 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
08/30/2007US20070203095 Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
08/30/2007US20070203088 Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease
08/30/2007US20070203087 Chondroitin sulfate synthesis promoter
08/30/2007US20070203074 Composition and method for the efficacious and safe administration of halopyruvate for the treatment of cancer
08/30/2007US20070203073 SARS and Ebola inhibitors and use thereof, and methods for their discovery
08/30/2007US20070203072 Hcv Ns-3 Serine Protease Inhibitors
08/30/2007US20070203071 Conformationally Constrained Parthyroid Hormone (Pth) Analogs
08/30/2007US20070203070 28 human secreted proteins
08/30/2007US20070203069 Grf-containing lyophilized pharmaceutical compositions
08/30/2007US20070203068 Stimulation of beta cell proliferation
08/30/2007US20070203067 Therapeutic, prophylactic, and diagnostic agent for cancer, useful for characterizing cancer cells with individual properties
08/30/2007US20070203066 Compositions and methods for inhibiting cellular proliferation
08/30/2007US20070203065 Insulin-Independent, Bone Morphogenetic Protein (Bmp)-Mediated Uptake Of Blood Glucose By Peripheral Cells And Tissues
08/30/2007US20070203064 TLR3 Glycosylation Site Muteins and Methods of Use
08/30/2007US20070203063 Pharmaceutical compositions including variants of vascular endothelial cell growth factor having altererd pharmacological properties
08/30/2007US20070203062 Compositions and methods for promoting hemostasis and other physiological activities
08/30/2007US20070203061 Adiponectin expression-inducing agents and uses thereof
08/30/2007US20070203060 Casein Derived Peptides And Therapeutic Uses Thereof
08/30/2007US20070203059 Targeted Drug-Formaldehyde Conjugates And Methods Of Making And Using The Same
08/30/2007US20070203058 Novel Glp-1 Derivatives
08/30/2007US20070203057 Compounds and methods for modulating adhesion molecule function
08/30/2007US20070203056 novel antiproliferative factor and methods of use
08/30/2007US20070203055 Compounds and compositions for prevention of overdose of oxycodone
08/30/2007US20070203054 Fragments of nkp44 for targeting viral-infected and tumor cells
08/30/2007US20070202575 Asthma; ellergy vaccine; antisense therapy; used to treat, prevent, or ameliorate the symptoms resulting from exposure to a bio-warfare agent
08/30/2007US20070202566 Hydrolases, Nucleic Acids Encoding Them And Methods For Making And Using Them
08/30/2007US20070202563 hydrolase enzymes useful for degrading and analyzing polysaccharides such as glycosaminoglycans including chondroitin sulfate, dermatan sulfate, unsulfated chondroitin and hyaluronan; promotere of nerve regeneration, stroke recovery, treating spinal cord injury,epithelial disease, infections and cancers
08/30/2007US20070202551 TGFBeta
08/30/2007US20070202544 Methods For Diagnosing And Treating Endoplasmic Reticulum (er) Stress Diseases
08/30/2007US20070202520 Novel lipase
08/30/2007US20070202516 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy
08/30/2007US20070202506 Single nucleotide polymorphisms predicting cardiovascular disease
08/30/2007US20070202501 Proteins Expressed In Ink Cells
08/30/2007US20070202203 Anti-ageing composition
1 ... 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 ... 3163